Skip to main content

Platelet-mediated thrombosis and drug-eluting stents.

Publication ,  Journal Article
Granada, JF; Price, MJ; French, PA; Steinhubl, SR; Cutlip, DE; Becker, RC; Smyth, SS; Dauerman, HL
Published in: Circ Cardiovasc Interv
December 1, 2011

Duke Scholars

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

December 1, 2011

Volume

4

Issue

6

Start / End Page

629 / 637

Location

United States

Related Subject Headings

  • Ticlopidine
  • Thiophenes
  • Risk Factors
  • Purinergic P2Y Receptor Antagonists
  • Prasugrel Hydrochloride
  • Platelet Activation
  • Piperazines
  • Humans
  • Equipment Design
  • Drug-Eluting Stents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Granada, J. F., Price, M. J., French, P. A., Steinhubl, S. R., Cutlip, D. E., Becker, R. C., … Dauerman, H. L. (2011). Platelet-mediated thrombosis and drug-eluting stents. Circ Cardiovasc Interv, 4(6), 629–637. https://doi.org/10.1161/CIRCINTERVENTIONS.111.964635
Granada, Juan F., Matthew J. Price, Patricia A. French, Steven R. Steinhubl, Donald E. Cutlip, Richard C. Becker, Susan S. Smyth, and Harold L. Dauerman. “Platelet-mediated thrombosis and drug-eluting stents.Circ Cardiovasc Interv 4, no. 6 (December 1, 2011): 629–37. https://doi.org/10.1161/CIRCINTERVENTIONS.111.964635.
Granada JF, Price MJ, French PA, Steinhubl SR, Cutlip DE, Becker RC, et al. Platelet-mediated thrombosis and drug-eluting stents. Circ Cardiovasc Interv. 2011 Dec 1;4(6):629–37.
Granada, Juan F., et al. “Platelet-mediated thrombosis and drug-eluting stents.Circ Cardiovasc Interv, vol. 4, no. 6, Dec. 2011, pp. 629–37. Pubmed, doi:10.1161/CIRCINTERVENTIONS.111.964635.
Granada JF, Price MJ, French PA, Steinhubl SR, Cutlip DE, Becker RC, Smyth SS, Dauerman HL. Platelet-mediated thrombosis and drug-eluting stents. Circ Cardiovasc Interv. 2011 Dec 1;4(6):629–637.

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

December 1, 2011

Volume

4

Issue

6

Start / End Page

629 / 637

Location

United States

Related Subject Headings

  • Ticlopidine
  • Thiophenes
  • Risk Factors
  • Purinergic P2Y Receptor Antagonists
  • Prasugrel Hydrochloride
  • Platelet Activation
  • Piperazines
  • Humans
  • Equipment Design
  • Drug-Eluting Stents